Modulation of specific [3H]phenytoin binding by benzodiazepines

Area of Science:

• Neuropharmacology
• Receptor Binding Assays

Background:

• Benzodiazepines are known modulators of the GABA-A receptor.
• Phenytoin is an anticonvulsant drug whose binding mechanisms are not fully elucidated.
• The existence and role of peripheral benzodiazepine receptors are under investigation.

Purpose of the Study:

• To investigate the interaction of various benzodiazepines with [3H]phenytoin binding.
• To explore the potential involvement of benzodiazepine receptors and GABA-chloride ionophores in phenytoin binding.
• To characterize a potential micromolar benzodiazepine receptor site.

Main Methods:

• Radioligand binding assays using [3H]phenytoin.
• Testing the effects of various benzodiazepines, picrotoxin, and chloride ions on binding.
• Determining ED50 and IC50 values for different compounds.
• Time-course studies to assess equilibrium.

Main Results:

• Diazepam, flunitrazepam, and Ro5-4864 enhanced [3H]phenytoin binding, with optimal enhancement at 3-4 hours.
• Picrotoxin and chloride ions inhibited this enhancement.
• Clonazepam, oxazepam, chlordiazepoxide, and Ro8682-10 inhibited [3H]phenytoin binding within 45 minutes, independent of chloride or picrotoxin.
• Nitrazepam and several tetralobenzodiazepines showed no effect.

Conclusions:

• Data suggest the involvement of both peripheral benzodiazepine receptors and GABA-chloride ionophores in some benzodiazepine-mediated enhancements of [3H]phenytoin binding.
• A distinct micromolar benzodiazepine receptor site, potentially involved in CNS excitability, is indicated by the inhibitory effects of other benzodiazepines.
• These findings contribute to understanding the complex pharmacology of benzodiazepines and their interaction with anticonvulsant binding sites.